ottle tightly closed.
Keep VIMOVO dry.
Keep VIMOVO and all medicines out of the reach of children.
General information about VIMOVO
Medicines are sometimes prescribed for purposes other than those listed in this Medication Guide. Do not use VIMOVO for a condition for which it was not prescribed. Do not give VIMOVO to other people, even if they have the same symptoms you have. It may harm them.
This Medication Guide summarizes the most important information about VIMOVO. If you would like more information, ask your healthcare provider. You can ask your healthcare provider or pharmacist for information that is written for healthcare professionals.
For more information, call 1-800-236-9933 or go to www.VIMOVO.com
What are the ingredients in VIMOVO?
Active ingredients: naproxen and esomeprazole magnesium
Inactive ingredients: carnauba wax, colloidal silicon dioxide, croscarmellose sodium, iron oxide yellow, glyceryl monostearate, hypromellose, iron oxide black, magnesium stearate, methacrylic acid copolymer dispersion, methylparaben, polysorbate 80, polydextrose, polyethylene glycol, povidone, propylene glycol, propylparaben, titanium dioxide, and triethyl citrate.
Distributed by: AstraZeneca LP, Wilmington, DE 19850
Issued June 2011
This Medication Guide has been approved by the U.S. Food and Drug Administration.
VIMOVO is a trademark of the AstraZeneca group of companies.
Other trademarks are the property of their respective companies.
PACKAGE LABEL - VIMOVO 375 / 20 MG TABLET
VIMOVO
naproxen and esomeprazole magnesium tablet, delayed release
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:16590-957(NDC:0186-0510)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
NAPROXEN (NAPROXEN) NAPROXEN 375mg
ESOMEPRAZOLE MAGNESIUM (ESOMEPRAZOLE) ESOMEPRAZOLE MAGNESIUM 20mg
Inactive Ingredients
Ingredient Name Strength
CARNAUBA WAX
SILICON DIOXIDE
CROSCARMELLOSE SODIUM
FERRIC OXIDE YELLOW
GLYCERYL MONOSTEARATE
HYPROMELLOSES
MAGNESIUM STEARATE
METHACRYLIC ACID
METHYLPARABEN
POLYSORBATE 80
POLYETHYLENE GLYCOL
POVIDONE
PROPYLENE GLYCOL
PROPYLPARABEN
TITANIUM DIOXIDE
TRIETHYL CITRATE
FERROSOFERRIC OXIDE
POLYDEXTROSE
Product Characteristics
Color yellow (FILM-COATED) Score no score
Shape OVAL Size 17mm
Flavor Imprint Code 375;20
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:16590-957-30 30 TABLET, DELAYED RELEASE ( TABLET) in 1 BOTTLE None
2 NDC:16590-957-60 60 TABLET, DELAYED RELEASE ( TABLET) in 1 BOTTLE None
3 NDC:16590-957-90 90 TABLET, DELAYED RELEASE ( TABLET) in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA022511 07/01/2011
Labeler -STAT RX USA LLC (786036330)
Establishment
Name Address ID/FEI Operations
STAT RX USA LLC 786036330 relabel,repack